Chi-med stock price

Chi-Med prices US public offering. Hutchison China MediTech has announced the pricing of the US public offering of American Depositary Shares on Nasdaq 

Hutchison China MediTech Ltd, HCM:LSE summary - FT.com Latest Hutchison China MediTech Ltd (HCM:LSE) share price with interactive charts, historical prices, comparative analysis, forecasts, business profile and more. Biotech group Chi-Med plans Hong Kong listing of up to ... Apr 15, 2019 · HONG KONG (Reuters) - Biotech company Hutchison China MediTech, known as Chi-Med, has filed for a Hong Kong listing, which four sources close …

Calamos Convertible Opportunities and Income Fund Common Stock (CHI) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

Barchart.com Inc. is the leading provider of real-time or delayed intraday stock and commodities charts and quotes. Keep tabs on your portfolio, search for stocks, commodities, or mutual funds with screeners, customizable chart indicators and technical analysis. Chi-Med Announces First Commercial Launch of Fruquintinib ... Nov 26, 2018 · Dual-listed on the AIM market of the London Stock Exchange and the Nasdaq Global Select Market, Chi-Med is headquartered in Hong Kong and majority owned by the multinational conglomerate CK HCM Stock Price & Charts | Hutchison China Meditech In depth view into HCM (Hutchison China Meditech) stock including the latest price, news, dividend history, earnings information and financials.

5 equities research analysts have issued 1 year price objectives for HUTCHISON CHINA/S's shares. Their forecasts range from $29.00 to $29.00. On average, they expect HUTCHISON CHINA/S's stock price to reach $29.00 in the next year. This suggests a possible upside of 67.1% from the stock's current price.

Chi Med Announces Secondary Offering Of American ... Barchart.com Inc. is the leading provider of real-time or delayed intraday stock and commodities charts and quotes. Keep tabs on your portfolio, search for stocks, commodities, or mutual funds with screeners, customizable chart indicators and technical analysis. Chi-Med Announces First Commercial Launch of Fruquintinib ...

Jan 23, 2020 · Hutchison China MediTech Ltd. (Nasdaq: HCM) priced its $110 million offering at $25 per American depositary share on Wednesday.. The cancer drug developer, which is dual-listed on the AIM market of the London Stock Exchange and the Nasdaq Global Select Market, saw its Nasdaq stock price drop 13% on Wednesday from $29.50 to $25.69 on the offering announcement.

Why Chi-Med Stock Is Tanking Today

Hutchison China MediTech Limited American Depositary Shares (HCM) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

Hutchison China MediTech, or Chi-Med, is an innovative biopharmaceutical company which researches, develops, manufactures and markets pharmaceutical products HCM | Hutchison China MediTech Ltd. ADR Overview | MarketWatch Hutchison China MediTech Ltd. ADR. Hutchison China MediTech Ltd. is a holding company, which engages in the research and development, manufactures, …

Hutchison China MediTech Limited American Depositary ... Hutchison China MediTech Limited American Depositary Shares (HCM) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. HCM Stock Price, Forecast & News (HUTCHISON CHINA/S) 5 equities research analysts have issued 1 year price objectives for HUTCHISON CHINA/S's shares. Their forecasts range from $29.00 to $29.00. On average, they expect HUTCHISON CHINA/S's stock price to reach $29.00 in the next year. This suggests a possible upside of 67.1% from the stock's current price. Chi-Med Hutchison China MediTech, or Chi-Med, is an innovative biopharmaceutical company which researches, develops, manufactures and markets pharmaceutical products HCM | Hutchison China MediTech Ltd. ADR Overview | MarketWatch